ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026
CRISPR-Cas-based activation of PPARGC1A boosts endogenous mitochondria and enhances cardiac function after myocardial infarction.
Mario Escobar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.